Sunday, August 26, 2012

Health - Google News: FDA Panel to Review Humira Colitis Data - MedPage Today

Health - Google News
Google News
FDA Panel to Review Humira Colitis Data - MedPage Today
Aug 24th 2012, 22:01


FDA Panel to Review Humira Colitis Data
MedPage Today
By Nancy Walsh, Staff Writer, MedPage Today Further studies may be needed to demonstrate clear benefits for the tumor necrosis factor (TNF) inhibitor adalimumab (Humira) in ulcerative colitis, FDA staff suggested. In briefing documents prepared in ...
Potential colitis drug may need more studies: FDAHealthNews
Abbott's Humira May Not Be Effective in Colitis, FDA SaysBloomberg
Abbott may need more Humira studies, FDA staff sayReuters
Chicago Tribune
all 27 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

0 comments:

Post a Comment

Twitter Delicious Facebook Digg Stumbleupon Favorites More